Friday, 1 May 2026

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer - The New York Times

  1. F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer  The New York Times
  2. FDA green lights early access to pancreatic cancer drug, daraxonrasib  USA Today
  3. Groundbreaking advancements in pancreatic cancer treatment excite UW Health doctor  WKOW
  4. Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer  Nature
  5. US FDA authorizes early access to Revolution's pancreatic cancer pill  Yahoo


from Top stories - Google News https://ift.tt/LJrOFM2
via Whole story

No comments:

Post a Comment